Some of the algorithms were only applicable following a robust diagnosis of PA as the algorithm itself did not include markers of hyperaldosteronism (e.g. CT imaging and age without aldosterone or renin), while other algorithms could be applied following initial screening based on the patient’s aldosterone, renin, potassium and CT imaging. This evidence concerns the gene REN and hyperaldosteronism.